179 related articles for article (PubMed ID: 12833175)
1. Uptake of photofrin II, a photosensitizer used in photodynamic therapy, by tumour cells in vitro.
Chwiłkowska A; Saczko J; Modrzycka T; Marcinkowska A; Malarska A; Bielewicz J; Patalas D; Banaś T
Acta Biochim Pol; 2003; 50(2):509-13. PubMed ID: 12833175
[TBL] [Abstract][Full Text] [Related]
2. Cellular accumulation and biological activity of hematoporphyrin derivative(L) in comparison with photofrin II.
Khanum F; Jain V
Indian J Exp Biol; 1997 Apr; 35(4):348-55. PubMed ID: 9315233
[TBL] [Abstract][Full Text] [Related]
3. Characterization of Photofrin photobleaching for singlet oxygen dose estimation during photodynamic therapy of MLL cells in vitro.
Dysart JS; Patterson MS
Phys Med Biol; 2005 Jun; 50(11):2597-616. PubMed ID: 15901957
[TBL] [Abstract][Full Text] [Related]
4. Effect of pH on uptake and photodynamic action of chlorin p6 on human colon and breast adenocarcinoma cell lines.
Sharma M; Dube A; Bansal H; Kumar Gupta P
Photochem Photobiol Sci; 2004 Feb; 3(2):231-5. PubMed ID: 14872242
[TBL] [Abstract][Full Text] [Related]
5. [Main factors affecting the effect of photodynamic therapy against human esophageal cancer cells in vitro].
Chen XH; Luo RC; Li LB; Ding XM; Lü CW; Zhou XP; Yan X
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Dec; 27(12):1817-20. PubMed ID: 18158991
[TBL] [Abstract][Full Text] [Related]
6. Phototoxicity, redox behavior, and pharmacokinetics of benzophenoxazine analogues in EMT-6 murine sarcoma cells.
Cincotta L; Foley JW; Cincotta AH
Cancer Res; 1993 Jun; 53(11):2571-80. PubMed ID: 8495421
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo photosensitizing applications of Photofrin in malignant melanoma cells.
Chang CJ; Yu JS; Wei FC
Chang Gung Med J; 2008; 31(3):260-7. PubMed ID: 18782948
[TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy and some clinical applications in oncology.
Dima VF; Ionescu MD; Balotescu C; Dima SF
Roum Arch Microbiol Immunol; 2002; 61(3):159-205. PubMed ID: 14752983
[TBL] [Abstract][Full Text] [Related]
9. Tolyporphin: a natural product from cyanobacteria with potent photosensitizing activity against tumor cells in vitro and in vivo.
Morlière P; Mazière JC; Santus R; Smith CD; Prinsep MR; Stobbe CC; Fenning MC; Golberg JL; Chapman JD
Cancer Res; 1998 Aug; 58(16):3571-8. PubMed ID: 9721863
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous two-photon excitation of photofrin in relation to photodynamic therapy.
Karotki A; Khurana M; Lepock JR; Wilson BC
Photochem Photobiol; 2006; 82(2):443-52. PubMed ID: 16613497
[TBL] [Abstract][Full Text] [Related]
11. The phototoxicity of photofrin was enhanced by PEGylated liposome in vitro.
Sadzuka Y; Tokutomi K; Iwasaki F; Sugiyama I; Hirano T; Konno H; Oku N; Sonobe T
Cancer Lett; 2006 Sep; 241(1):42-8. PubMed ID: 16303246
[TBL] [Abstract][Full Text] [Related]
12. Photodynamic effects of porphyrin and chlorin photosensitizers in human colon adenocarcinoma cells.
Banfi S; Caruso E; Caprioli S; Mazzagatti L; Canti G; Ravizza R; Gariboldi M; Monti E
Bioorg Med Chem; 2004 Sep; 12(18):4853-60. PubMed ID: 15336264
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic therapy with photofrin reduces invasiveness of malignant human glioma cells.
Jiang F; Chopp M; Katakowski M; Cho KK; Yang X; Hochbaum N; Tong L; Mikkelsen T
Lasers Med Sci; 2002; 17(4):280-8. PubMed ID: 12417983
[TBL] [Abstract][Full Text] [Related]
14. Role of mitochondria in cell death induced by Photofrin-PDT and ursodeoxycholic acid by means of SLIM.
Kinzler I; Haseroth E; Hauser C; Rück A
Photochem Photobiol Sci; 2007 Dec; 6(12):1332-40. PubMed ID: 18046490
[TBL] [Abstract][Full Text] [Related]
15. Clinical pharmacokinetics of the PDT photosensitizers porfimer sodium (Photofrin), 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (Photochlor) and 5-ALA-induced protoporphyrin IX.
Bellnier DA; Greco WR; Loewen GM; Nava H; Oseroff AR; Dougherty TJ
Lasers Surg Med; 2006 Jun; 38(5):439-44. PubMed ID: 16634075
[TBL] [Abstract][Full Text] [Related]
16. Comparation of liposomal formulations of ALA Undecanoyl ester for its use in photodynamic therapy.
Di Venosa G; Hermida L; Fukuda H; Defain MV; Rodriguez L; Mamone L; MacRobert A; Casas A; Batlle A
J Photochem Photobiol B; 2009 Aug; 96(2):152-8. PubMed ID: 19560367
[TBL] [Abstract][Full Text] [Related]
17. Time-resolved fluorescence spectroscopy of a hematoporphyrin derivative used for photodynamic therapy of cancer.
Gottschlich S; Lippert BM; Schade W; Werner JA
Res Commun Mol Pathol Pharmacol; 1997 Nov; 98(2):237-40. PubMed ID: 9467832
[TBL] [Abstract][Full Text] [Related]
18. Antitumor effect of photodynamic therapy in mice using direct application of Photofrin dissolved in lidocaine jelly.
Murakami H; Kohno E; Kohmura Y; Ozawa H; Ito H; Sugihara K; Horiuchi K; Hirano T; Kanayama N
Photodermatol Photoimmunol Photomed; 2009 Oct; 25(5):259-63. PubMed ID: 19747245
[TBL] [Abstract][Full Text] [Related]
19. Tailor-made approach to photodynamic therapy in the treatment of cancer based on Bcl-2 photodamage.
Usuda J; Hirata T; Ichinose S; Ishizumi T; Inoue T; Ohtani K; Maehara S; Yamada M; Tsutsui H; Okunaka T; Kato H; Ikeda N
Int J Oncol; 2008 Oct; 33(4):689-96. PubMed ID: 18813781
[TBL] [Abstract][Full Text] [Related]
20. In vitro photodynamic treatment of normal and human papilloma virus-transfected keratinocytes with photofrin II and red light.
Bernstein EF; Glass JM; DeGraff WG; Schlegel R; Black C; Fisher JM; Cook SN; Glatstein E; Russo A; Mitchell JB
Arch Dermatol; 1991 May; 127(5):683-7. PubMed ID: 1850973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]